Synopsys (SNSP) won European Union approval for its planned $35 billion purchase of Ansys (ANSS). Synopsys agreed to sell its ...

Learn why Humana is focusing on Medicare Advantage and healthcare services despite current challenges, with potential for ...

Former Tesla board member Antonio Gracias offers to rescue Lykos Therapeutics with $100M deal to save its psychedelic drug ...

Energy stocks started out 2024 great, but they start out 2025 in a slump after stumbling into the new year. The oil sector is ...

Wolfe Research upgrades Plains All American Pipeline, saying the stock trades at the lowest EV/EBITDA multiple in its ...

Analysis of December's strong jobs report, indicating a robust labor market and potential impact on Fed rate decisions. Click ...

I have become bullish on Tile Shop due to expected improvements in top line performance and gross profit margins. Read the ...

SkyWest's strong fundamentals include predictable revenues from capacity purchase agreements, consistent debt reduction, and ...

GBTC, now the third-largest Bitcoin ETF by AUM, suffers from its uncompetitive 1.50% expense ratio. Read my analysis.

High Tide, a cannabis retailer founded in 2009, showcases steady growth and plans for global expansion amid industry ...

Microvast Holdings' ASSB is a game-changer, but profitability issues loom. Learn why MVST stock could face challenges despite ...

UnitedHealth's valuation metrics indicate a potential buy-the-dip opportunity, with forward ratios mostly below their ...